Skip to main content
Log in

5′-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice

  • Original Articles
  • 5′-Deoxy-5-Fluorouridine, Cancer Cachexia, Colon 26, Adenocarcinoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The cytostatic agent 5′-deoxy-5-fluorouridine (5′-dFUrd) improves cachexia and prolongs survival, suppressing tumor growth in mice bearing large burdens of colon 26 adenocarcinoma. To investigate the mode of this anticachectic action, we isolated colon 26 variants that were resistant to the anticachectic activity in vivo in tumorbearing mice that initially responded to 5′-dFUrd in terms of tumor growth and cachexia but again became cachectic and refractory to the drug after prolonged treatment. The original line and variants were equally susceptible to the antiproliferative action of 5′-dFUrd, and their growth was stopped. However, 5′-dFUrd given to cachectic mice exhibiting large burdens of these variants could not reverse wasting and only slightly prolonged the survival period. These results indicate that the anticachectic activity of 5′-dFUrd is independent of its antiproliferative action and that the survival of colon 26-bearing mice is shorter when the size of the tumors is not reduced to levels below those that cause cachexia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Armstrong RD, Cadman E (1983) 5′-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Res 43: 2525

    Google Scholar 

  2. Bollag W, Hartmann HR(1980) Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine. Eur J Cancer 16: 427

    Google Scholar 

  3. Connolly KM, Diasio RB, Armstrong RD, Kaplan AM (1983) Decreased immunosuppression associated with anticancer activity of 5′-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine. Cancer Res 43: 2529

    Google Scholar 

  4. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69: 491

    Google Scholar 

  5. Ghezzi P, Saccardo B, Villa P, Bianchi M, Dinarello CA (1986) Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun 54: 837

    Google Scholar 

  6. Ghezzi P, Saccardo B, Bianchi M (1986) Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem Biophys Res Commun 136: 316

    Google Scholar 

  7. Hyvärien A, Nikkílä EA (1962) Specific determination of blood glucose witho-toluidine. Clin Chim Acta 7: 140

    Google Scholar 

  8. Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama HB (1980) Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gann 71: 112

    Google Scholar 

  9. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y, Ishitsuka H (1983) Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull (Tokyo) 31: 175

    Google Scholar 

  10. Miwa M, Cook A, Ishitsuka H (1986) Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem Pharm Bull (Tokyo) 34: 4225

    Google Scholar 

  11. Ohta Y, Sueki K, Kitta K, Takemoto K, Ishitsuka H, Yagi Y (1980) Comparative studies on the immunosuppressive effect among 5′-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil. Gann 71: 190

    Google Scholar 

  12. Peters GJ, Braakhuis BJM, Bruijin EA de, Laurensse EJ, Walsum M van, Pinedo HM (1989) Enhanced therapeutic efficacy of 5′-deoxy-5-fluorouridine in 5-fluorouracil-resistant head and neck tumors in relation to 5-fluorouracil-metabolising enzymes. Br J Cancer 59: 327

    Google Scholar 

  13. Tanaka Y, Tanaka T, Ishitsuka H (1989) Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants. Cancer Res 49: 5935

    Google Scholar 

  14. Tanaka Y, Eda H, Tanaka T, Udagawa T, Ishikawa T, Horii I, Ishitsuka H, Kataoka T, Taguchi T (1990) Experimental cancer cachexia induced by colon 26 adenocarcinoma in mice. Cancer Res 50: 2290

    Google Scholar 

  15. Tanaka Y, Eda H, Fujimoto K, Tanaka T, Ishitsuka H (1990) Anticachectic activity of 5′-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res 50: 4528

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eda, H., Tanaka, Y. & Ishitsuka, H. 5′-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice. Cancer Chemother. Pharmacol. 29, 1–6 (1991). https://doi.org/10.1007/BF00686327

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686327

Keywords

Navigation